Form 4: Coliseum Capital Receives Warrants in Purple Innovation Following Credit Agreement Amendment

Coliseum Capital Management and related entities received warrants to purchase Purple Innovation Class A common stock as part of an amendment to a credit agreement.

Summary

• Coliseum Capital Management, LLC, along with related entities including Coliseum Capital, LLC, Coliseum Capital Partners, L.P., Coliseum Capital Co-Invest III, L.P., Adam Gray, and Christopher Shackelton, filed a Form 4 regarding changes in beneficial ownership of Purple Innovation, Inc. securities.
• The filing reports the acquisition of warrants by these entities on May 2, 2025, as partial consideration for a $20,000,000 loan made to a subsidiary of Purple Innovation.
• The warrants entitle the holder to purchase one share of Purple Innovation's Class A common stock at a price of $1.50 per share, subject to adjustment.
• A total of 6,557,377 warrants were issued.
• The warrants are subject to a contractual limitation preventing exercise if it would result in the holder owning more than 49.9% of the outstanding Class A Common Stock.
• As of May 2, 2025, based on 108,221,494 shares of Class A Common Stock outstanding, the warrants could be exercised for an aggregate of 14,276,618 shares.
• Adam Gray is a director of Purple Innovation, and as a result, CCM, CC, CCP, CCC III and Shackelton may be deemed directors by deputization.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The warrant issuance provides Purple Innovation with needed capital, but also introduces potential dilution for existing shareholders. The involvement of Coliseum Capital is a positive signal.

Positives

• The investment by Coliseum Capital provides Purple Innovation with $20,000,000 in funding.
• The structure of the warrants incentivizes Coliseum Capital to support Purple Innovation's success, as the warrants become more valuable as the share price increases.
• The long expiration date of the warrants (March 12, 2035) gives Coliseum Capital ample time to realize a return on their investment.

Negatives

• The issuance of warrants dilutes existing shareholders' ownership, although the extent of dilution is limited by the 49.9% ownership cap.
• The exercise of the warrants could put downward pressure on the share price if a large number of shares are issued at once.

Risks

• Purple Innovation's ability to repay the $20,000,000 loan is crucial to avoid potential financial distress.
• The value of the warrants is dependent on Purple Innovation's stock price, which is subject to market fluctuations and company-specific risks.
• The 49.9% ownership limitation on the warrants could restrict Coliseum Capital's ability to fully capitalize on their investment if Purple Innovation's stock price increases significantly.

Future Outlook

The document does not contain explicit forward-looking statements from Purple Innovation. However, the investment by Coliseum Capital suggests a belief in the company's future potential.

Industry Context

This transaction reflects a common practice of using warrants as part of financing agreements, particularly for companies seeking capital. The involvement of Coliseum Capital, a known investment firm, could signal confidence in Purple Innovation's prospects within the mattress and comfort technology industry.

Comparison to Industry Standards

• Warrant issuances are a fairly common practice in corporate finance, especially for smaller companies or those with higher risk profiles.
• The $1.50 exercise price is dependent on the current trading price of Purple Innovation's stock and the terms negotiated between the company and Coliseum Capital.
• Similar transactions can be seen with other companies in the consumer discretionary sector, where financing is often used to fund growth initiatives or manage debt.

Stakeholder Impact

• Shareholders may experience dilution if the warrants are exercised.
• Employees may benefit from the company's improved financial position due to the loan.
• Customers may see continued investment in product development and marketing.
• Suppliers may benefit from increased orders as the company grows.
• Creditors may view the loan as a positive sign of the company's ability to meet its obligations.

Next Steps

• Coliseum Capital may exercise the warrants in the future, depending on Purple Innovation's stock price and their investment strategy.
• Purple Innovation will need to manage the potential dilution from the warrant exercise.
• Investors should monitor Purple Innovation's financial performance and stock price to assess the impact of the warrant issuance.

Key Dates

Keywords

Purple Innovation, Coliseum Capital, Warrants, Form 4, Beneficial Ownership, Credit Agreement, Loan, Class A Common Stock